Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT ID: NCT01196884
Last Updated: 2018-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
190 participants
OBSERVATIONAL
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biologic Characterization of Patients With ITP
NCT05694325
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
NCT03465020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asymptomatic ITP patients
No interventions assigned to this group
ITP patients treated with Rituximab
No interventions assigned to this group
ITP patients treated with steroids
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Sanitaria-Universitaria Integrata di Udine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto di Ematologia L. & A. Seragnoli
Bologna, , Italy
Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco
Cagliari, , Italy
UF Ematologia, Policlinico di Careggi
Florence, , Italy
U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, , Italy
Department of Oncology/Haematology, Niguarda Ca'Granda Hospital
Milan, , Italy
Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro
Novara, , Italy
Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
Novara, , Italy
Department of Medical and Surgical Sciences, University of Padova
Padua, , Italy
Oncology-Hematology Department, "S. Maria delle Croci" Hospital
Ravenna, , Italy
Institute of Hematology, Catholic University,
Roma, , Italy
Ematologia, Ospedale Ca' Foncello
Treviso, , Italy
Clinica Ematologica AOUD S. Maria Misericordia
Udine, , Italy
Ematologia, San Bortolo Hospital
Vicenza, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nicola Vianelli, MD
Role: primary
Emilio Usala, MD
Role: primary
Antonella Gozzini, MD
Role: primary
Wilma Barcellini, MD
Role: primary
Silvia Cantoni, MD
Role: primary
Gianluca Gaidano, Prof.
Role: primary
Fabrizio Fabris, Prof.
Role: primary
Alfonso Zaccaria, MD
Role: primary
Valerio De Stefano, MD
Role: primary
Filippo Gherlinzoni, MD
Role: primary
Francesco Rodeghiero, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNIT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.